COVID-19疫情对缺血性心脏病心肌灌注显像的影响
该研究回顾性分析了意大利那不勒斯费德里科二世大学在2020年2月至5月疫情封锁期间与2017至2019年同期进行的负荷SPECT-MPI数量及结果。疫情期间检查量(n=123)显著低于往年同期均值(n=413,P<0.0001),但异常率相似(36% vs 34%,P=0.65),提示可能遗漏了大量潜在异常患者。
要点
- 疫情期间负荷SPECT-MPI检查量较往年同期均值显著下降(123 vs 413,P<0.0001)。
- 异常检查百分比疫情期间为36%,往年同期均值为34%,差异无统计学意义(P=0.65)。
- 检查量下降而异常率不变,提示可能遗漏了潜在异常影像检查的患者。
核心结论
- 疫情期间负荷SPECT-MPI检查数量较2017至2019年同期显著减少,但异常率无差异,提示许多潜在异常患者被遗漏。
研究设计与样本
- 回顾性研究,比较2020年2月至5月疫情封锁期间与2017、2018、2019年对应月份在意大利那不勒斯费德里科二世大学进行的负荷SPECT-MPI的数量和结果。
主要发现
- 疫情期间负荷SPECT-MPI检查数为123例,显著低于2017至2019年对应月份年均413例(P<0.0001)。
- 疫情期间异常负荷SPECT-MPI占比36%,与2017至2019年对应期间均值34%相似(P=0.65)。
临床怎么用
- 疫情期间心肌灌注显像检查量显著下降而异常率不变,提示应关注可能被遗漏的缺血性心脏病患者。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
PURPOSE: We assessed the effects of the COVID-19 pandemic on myocardial perfusion imaging (MPI) for ischemic heart disease during the lockdown imposed by the Italian Government. METHODS: We retrospectively reviewed the number and the findings of stress single-photon emission computed tomography (SPECT)-MPI performed between February and May 2020 during the COVID-19 pandemic at the University of Napoli Federico II. The number and the findings of stress SPECT-MPI studies acquired in the corresponding months of the years 2017, 2018, and 2019 were also evaluated for direct comparison. RESULTS: The number of stress SPECT-MPI studies performed during the COVID-19 pandemic (n = 123) was significantly lower (P < 0.0001) compared with the mean yearly number of procedures performed in the corresponding months of the years 2017, 2018, and 2019 (n = 413). Yet, the percentage of abnormal stress SPECT-MPI studies was similar (P = 0.65) during the pandemic (36%) compared with the mean percentage value of the corresponding period of the years 2017, 2018, and 2019 (34%). CONCLUSION: The number of stress SPECT-MPI studies was significantly reduced during the COVID-19 pandemic compared with the corresponding months of the previous 3 years. The lack of difference in the prevalence of abnormal SPECT-MPI studies between the two study periods strongly suggests that many patients with potentially abnormal imaging test have been missed during the pandemic.
引用
- Nappi C, Megna R, Acampa W, et al. Effects of the COVID-19 pandemic on myocardial perfusion imaging for ischemic heart disease. Eur J Nucl Med Mol Imaging. 2020. PMID: 32778930. doi:10.1007/s00259-020-04994-6
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。